• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Sweden·Healthcare·PRO.ST
Share

Promimic AB (publ) Stocks

SEK 9.55Last Updated 21.10.2026

Issuer Rating

2/7
Performance

Modest

Risk

High

Recommendation

Sell

Market Cap

SEK 18.21M

SEK 9.55
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Very low or no dividends

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Promimic AB (publ) is dedicated to developing, commercializing, and supplying specialized biomaterials designed to enhance the integration of bone with orthopedic and dental implants. A core offering is its proprietary HAnano surface technology, an innovative solution that integrates a range of characteristics known to significantly optimize bone-to-implant bonding into a single, distinct surface modification. Established in 2004, the company's operations are headquartered in Mölndal, Sweden.

Company Valuation

Overvalued
2/7

From both historical and forecast perspectives, the stock is overpriced compared to similar stocks.

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

24.10.2026 00:50

An analyst has shifted from a "bearish" view on SpaceX stock to a "bullish" one. What has changed?

23.10.2026 23:10

Wall Street is split on Meta’s outlook. Should investors buy the current dip?

23.10.2026 21:58

Brent crude jumps above $117 for first time since April

23.10.2026 21:02

GM is on track for its worst week since the start of 2025. Should you buy shares on the dip?

23.10.2026 20:18

Morgan Stanley picks 24 AI infrastructure stocks built to weather spending slowdown

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026